M&A TRANSACTION · 2019
RoseRock Healthcare acquired by Amedisys, Inc.
$17.5M· 8.8x EBITDA· 1.80x revenue
Target
RoseRock Healthcare
Acquirer
Amedisys, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$10.0M
EBITDA
$2.0M
Deal Value
$17.5M
EV/EBITDA
8.8x
Context
This $17.5M acquisition of RoseRock Healthcare by Amedisys, Inc. sits in the hospice sub-vertical. The 8.8x EBITDA multiple paid in 2019 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. Amedisys, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price hospice businesses on our Hospice strategic buyer-pool page.
Source
Data sourced from SEC filings and cost reports. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own hospice
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the RoseRock Healthcare acquisition.